DNA methylation episignature in Gabriele-de Vries syndrome.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
04 2022
Historique:
received: 08 12 2021
accepted: 08 12 2021
pubmed: 15 1 2022
medline: 13 4 2022
entrez: 14 1 2022
Statut: ppublish

Résumé

Gabriele-de Vries syndrome (GADEVS) is a rare genetic disorder characterized by developmental delay and/or intellectual disability, hypotonia, feeding difficulties, and distinct facial features. To refine the phenotype and to better understand the molecular basis of the syndrome, we analyzed clinical data and performed genome-wide DNA methylation analysis of a series of individuals carrying a YY1 variant. Clinical data were collected for 13 individuals not yet reported through an international call for collaboration. DNA was collected for 11 of these individuals and 2 previously reported individuals in an attempt to delineate a specific DNA methylation signature in GADEVS. Phenotype in most individuals overlapped with the previously described features. We described 1 individual with atypical phenotype, heterozygous for a missense variant in a domain usually not involved in individuals with YY1 pathogenic missense variations. We also described a specific peripheral blood DNA methylation profile associated with YY1 variants. We reported a distinct DNA methylation episignature in GADEVS. We expanded the clinical profile of GADEVS to include thin/sparse hair and cryptorchidism. We also highlighted the utility of DNA methylation episignature analysis for classification of variants of unknown clinical significance.

Identifiants

pubmed: 35027293
pii: S1098-3600(21)05422-8
doi: 10.1016/j.gim.2021.12.003
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

905-914

Informations de copyright

Crown Copyright © 2021. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest The authors declare no conflict of interest.

Auteurs

Florian Cherik (F)

Department of Medical Genetics, Reference Centre for Rare Diseases, Developmental Anomalies and Malformation Syndromes Sud-Est, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Jack Reilly (J)

Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.

Jennifer Kerkhof (J)

Molecular Diagnostics Program and Verspeeten Clinical Genome Centre, London Health Sciences and Saint Joseph's Healthcare, London, Ontario, Canada.

Michael Levy (M)

Molecular Diagnostics Program and Verspeeten Clinical Genome Centre, London Health Sciences and Saint Joseph's Healthcare, London, Ontario, Canada.

Haley McConkey (H)

Molecular Diagnostics Program and Verspeeten Clinical Genome Centre, London Health Sciences and Saint Joseph's Healthcare, London, Ontario, Canada.

Mouna Barat-Houari (M)

Autoinflammatory and Rare Diseases Unit, Medical Genetic Department for Rare Diseases and Personalized Medicine, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Kameryn M Butler (KM)

Greenwood Genetic Center, JC Self Research Institute of Human Genetics, Greenwood, SC.

Christine Coubes (C)

Medical Genetic Department for Rare Diseases and Personalized Medicine, Montpellier University Hospital, Montpellier, France.

Jennifer A Lee (JA)

Greenwood Genetic Center, JC Self Research Institute of Human Genetics, Greenwood, SC.

Gwenael Le Guyader (G)

Clinical Genetics Department, Poitiers University Hospital, Poitiers, France.

Raymond J Louie (RJ)

Greenwood Genetic Center, JC Self Research Institute of Human Genetics, Greenwood, SC.

Wesley G Patterson (WG)

Greenwood Genetic Center, JC Self Research Institute of Human Genetics, Greenwood, SC.

Matthew L Tedder (ML)

Greenwood Genetic Center, JC Self Research Institute of Human Genetics, Greenwood, SC.

Mads Bak (M)

Clinical genetic department, Righospitalet, Copenhagen, Denmark.

Trine Bjørg Hammer (TB)

Clinical genetic department, Righospitalet, Copenhagen, Denmark; Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund, Denmark.

William Craigen (W)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.

Florence Démurger (F)

Medical Genetics Department, Bretagne-Atlantique Hospital, Vannes, France.

Christèle Dubourg (C)

Department of Molecular Genetics and Genomics, Rennes University Hospital, Rennes, France; Univ Rennes, CNRS, IGDR, UMR 6290, Rennes, France.

Mélanie Fradin (M)

Department of Clinical Genetics, Reference Centre for Rare Diseases, CLAD Ouest, Rennes University Hospital, Rennes, France.

Rachel Franciskovich (R)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston, TX.

Eirik Frengen (E)

Department of Medical Genetics, Oslo University Hospitals and University of Oslo, Oslo, Norway.

Jennifer Friedman (J)

Departments of Neurosciences and Pediatrics, University of California San Diego, San Diego, CA; Division of Neurology, Rady Children's Hospital, San Diego, CA; Rady Children's Institute for Genomic Medicine, Rady Children's Hospital, San Diego, CA.

Nathalie Ruiz Palares (NR)

Autoinflammatory and Rare Diseases Unit, Medical Genetic Department for Rare Diseases and Personalized Medicine, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.

Maria Iascone (M)

Medical Genetics Laboratory, ASST Papa Giovanni XXIII, Bergamo, Italy.

Doriana Misceo (D)

Department of Medical Genetics, Oslo University Hospitals and University of Oslo, Oslo, Norway.

Pauline Monin (P)

Department of Medical Genetics, Women Mother Children Hospital, Hospices Civils de Lyon, Lyon, France.

Sylvie Odent (S)

Department of Medical Genetics, Reference Center for Developmental Anomalies, CLAD Ouest, Rennes University Hospital, ERN ITHACA, CNRS UMR 6290, Genetics and Development Institute, Rennes University, Rennes, France.

Christophe Philippe (C)

Functional Unit of Innovative Diagnosis for Rare Diseases, Dijon Bourgogne University Hospital, Dijon, France.

Flavien Rouxel (F)

Medical Genetic Department for Rare Diseases and Personalized Medicine, Montpellier University Hospital, Montpellier, France.

Veronica Saletti (V)

Developmental Neurology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Petter Strømme (P)

Division of Pediatric and Adolescent Medicine, Oslo University Hospital, and University of Oslo, Oslo, Norway.

Perla Cassayre Thulin (PC)

Department of Neurology, University of Utah, Salt Lake City, UT.

Bekim Sadikovic (B)

Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada; Molecular Diagnostics Program and Verspeeten Clinical Genome Centre, London Health Sciences and Saint Joseph's Healthcare, London, Ontario, Canada. Electronic address: bekim.sadikovic@lhsc.on.ca.

David Genevieve (D)

Medical Genetic Department for Rare Diseases and Personalized Medicine, Montpellier University Hospital, Montpellier, France. Electronic address: d-genevieve@chu-montpellier.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH